4.2.2022 Recommendation: ''Criteria for continued treatment with nusinersen.'' Approved at the meeting of COHERE on 4 september 2019.
4.2.2022 Nusinersen in treating Spinal Muscular Atropy (SMA) - Approved at the meeting of COHERE on 15 March 2018.
